JJ PHARMA CONSULT ApS: Financial statements 2018
CVR: 33257635
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -40,319 and a net result of DKK -42,594 compared with DKK 585,060 the year before. Equity in the 2018 report amounted to DKK 1,963,614. The solvency ratio was 99.2%.
- Gross Profit
- DKK -40,319
- Profit/Loss
- DKK -42,594
- Equity
- DKK 1,963,614
- Total Assets
- DKK 1,979,922
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -40 t. | -43 t. | 2 mio. | 0 |
| 2017 | - | -18 t. | 585 t. | 2.1 mio. | - |
| 2016 | - | -45 t. | 315 t. | 1.6 mio. | - |
| 2015 | - | -17 t. | 582 t. | 1.4 mio. | - |
| 2014 | - | -23 t. | 920 t. | 934 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
JJ PHARMA CONSULT ApS has published its annual report for 2017. Gross profit came to DKK -18,228, and the net result was DKK 585,060.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.